This company is developing a device to administer high dose chemotherapy to the liver when cancer is present. The stock surged today after the company announced positive Phase III Clinical Data. Full trial data is planned to be released on June 5th.
Bio-Tech, Delcath Systems Inc. (DCTH)
Collapse
X
-
Dcth
Originally posted by dredre609 View PostThis company is developing a device to administer high dose chemotherapy to the liver when cancer is present. The stock surged today after the company announced positive Phase III Clinical Data. Full trial data is planned to be released on June 5th.
Comment
-
Comment